Optimizing Drug & CDx Development with Liquid CGP Under the Regulatory Requirements
- Interpretation of the accuracy for liquid-based assays as the follow-on CDx when the primary CDx is tissue-based
- What are the critical challenges trial sponsors face when designing and implementing global trials for efficient co-development of CDx?
- What are the challenges when developing CDx in rare cancers?